SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

SEC Comment Letter 0000000000-23-007956 to Pluri Inc. (PLUR)

Pluri Inc.
Date: July 25, 2023 · CIK: 0001158780 · Accession: 0000000000-23-007956

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-273347

Date
July 25, 2023
Author
Chen Franco-Yehuda
Form
UPLOAD
Company
Pluri Inc.

Letter

United States securities and exchange commission logo July 25, 2023 Chen Franco-Yehuda Chief Financial Officer and Treasurer Pluri Inc. MATAM Advanced Technology Park Building No. 5, Haifa L3 31905 Israel Re:Pluri Inc. Registration Statement on Form S-3 Filed July 20, 2023 File No. 333-273347 Dear Chen Franco-Yehuda: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Doris Stacey Gama at 202-551-3188 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Oded Har-Even, Esq.

Show Raw Text
United States securities and exchange commission logo
July 25, 2023
Chen Franco-Yehuda
Chief Financial Officer and Treasurer
Pluri Inc.
MATAM Advanced Technology Park
Building No. 5, Haifa L3 31905 Israel
Re:Pluri Inc.
Registration Statement on Form S-3
Filed July 20, 2023
File No. 333-273347
Dear Chen Franco-Yehuda:
            This is to advise you that we have not reviewed and will not review your registration
statement.
            Please refer to Rules 460 and 461 regarding requests for acceleration.  We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
            Please contact Doris Stacey Gama at 202-551-3188 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:       Oded Har-Even, Esq.